Search Results 3851-3860 of 15040 for CLL
-
Clinical Trials · Study Of Retinfanlimab In Combination With INCAGN02385 And INCAGN02390 As First-Line Treatment In Participants With PD-L1-Positive (CPS ≥ 1) ...
-
ROCHESTER, Minn. — Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for ...
-
People with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) – and chances are that it will ...
-
This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), ...
-
There is new hope in the fight against glioblastoma, the deadliest and most aggressive form of primary brain cancer. Currently there is no cure, but[...] ...
-
Their research appears in the Feb. 24 issue of JAMA, the journal of the American Medical Association. “As smokers quit earlier and stay off cigarettes longer, ...
-
ROCHESTER, Minn. — The American Heart Association and the Minnesota Department of Health recently recognized Mayo Clinic in Rochester as a Heart Safe ...
-
Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...
-
The purpose of this study is to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, ...
-
Cancer, stroke, bone loss among diseases and conditions studied in microgravity JACKSONVILLE, Florida — Mayo Clinic physician and researcher Dr. Abba ...